Vaccines in prophylaxis of urinary tract infections caused by the bacteria from the genus Proteus
Journal Title: Advances in Hygiene and Experimental Medicine - Year 2016, Vol 70, Issue
Abstract
Urinary tract infections (UTIs) pose a threat especially to women, the individuals with weakened immunity or with abnormalities in the urinary tract as well as to hospitalized and catheterized patients. The bacteria from the genus Proteus, especially P. mirabilis, are important UTI pathogenic factors. They frequently cause chronic, recurrent or severely complicated infections, resulting in the urinary stones production due to urease and other virulence factors. The ability to survive inside the stones and the increasing antibiotic resistance make it difficult to eradicate the bacteria from the urinary tract. A good solution to the problem may be the vaccination which obtained the interest from the surveyed persons, in spite of the antivaccination attitudes visible also in Poland. Currently, there are four vaccines available, composed of killed cells of different uropathogens, including Proteus spp. They are administrated intranassaly or vaginally and require many booster doses. They decrease the probability of reinfection in patients suffering from recurrent UTIs but the mechanisms of the immune response have not been exactly defined. Promising results were obtained in the studies on a mice model concerning the subunit, conjugated vaccines in which various P. mirabilis surface antigens (with the exception of flagellin) were successfully employed. Hitherto, the best results were obtained by the intranasal vaccinations, using MR/P fimbriae antigens with MPL or cholera toxin adjuvants and the antigens expressed in Lactococcus lactis or Salmonella Typhimurium. It led to an increase in the levels of the specific serum and mucosal antibodies resulting in the protection against P. mirabilis UTIs.
Authors and Affiliations
Dominika Drzewiecka, Gabriela Lewandowska
Keywords
Related Articles
- EP ID EP220866
- DOI -
- Views 139
- Downloads 0
Morganella sp. rods – characteristics, infections, mechanisms of resistance to antibiotics
The Morganella genus is one member of the tribe Proteae, which also includes the genera Proteus and Providencia. These bacteria are commonly present in the environment. Morganella sp. rods are known to be a causative ag...
Udział czynników genetycznych (polimorfizm PON1) i środowiskowych, a zwłaszcza aktywności fizycznej, w procesie antyoksydacyjnego działania paraoksynazy
Paraoksonaza 1 (PON1) należy do trójgenowej rodziny enzymów (PON1, PON2 i PON3). W osoczu człowieka dominuje aktywność PON1. Enzym ten wydzielany jest przez hepatocyty wątroby do krwi, gdzie wiąże się z lipoproteiną o du...
Renaturacja in vitro białek zakumulowanych w ciałach inkluzyjnych
Rekombinowane białka i enzymy dzięki ich heterologicznej ekspresji w prokariotycznych systemach ekspresyjnych są powszechnie wykorzystywane w diagnostyce, medycynie i przemyśle. Wysoki poziom ekspresji obcych białek w ko...
Chondrocytes apoptosis in osteoarthritis
Osteoarthritis (OA) is a type of degenerative joint disease where the balance between the degradation and the regeneration of articular cartilage is impaired, which leads to its progressive loss. This disease is the most...
Pharmacotherapy of Parkinson’s disease: Progress or regress?
Parkinson’s disease (PD) is a chronic, progressive disease of the central nervous system (CNS),characterized by a slow loss of dopaminergic neurons in the substantia nigra, leading to significantdecrease in dopamine (DA)...